Genex Pharmaceutical, Inc. (GENX) Research

Genex Pharmaceutical, Inc., operating within the People's Republic of China, specializes in the manufacturing and supply of its Reconstituted Bone Xenograft (RBX). This medical device is specifically designed to accelerate the healing process of bones. The company's products are distributed to an extensive network, reaching around 500 hospitals and numerous other customers in the medical device sector. Genex Pharmaceutical maintains its corporate headquarters in Tianjin City, China.

Market snapshot

Symbol
GENX
Price
$0.00
Day change
0.00%
Market cap
$1.8K
P/E ratio
0.01x
52-week range
0.0001-0.0002
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • The CannaBusiness Group, Inc. (CBGI)
  • Fiore Cannabis Ltd. (FIORF)
  • Green Growth Brands Inc. (GGBXF)
  • Juva Life Inc. (JUVAF)
  • Legacy Technology Holdings, Inc. (LTHO)
  • Wayland Group Corp. (MRRCF)
  • ONE Bio Corp. (ONBI)
  • Speakeasy Cannabis Club Ltd. (SPBBF)

Open Genex Pharmaceutical, Inc. (GENX) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.